HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone ," but experts say concerns about the abortion pill's safety are misguided.

A top official at the U.S. Food and Drug Administration (FDA) confirmed on Monday that the organization will conduct a review of the abortion drug mifepristone following several recent studies ...

Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad ...

As abortion-rights activists have pushed to loosen the FDA safety protocols, pro-life advocates have begun pushing in the opposite direction, rightly noting the potentially grave hazards to women ...

WEDNESDAY, July 16, 2025 (HealthDay News) — A federal appeals court has ruled that West Virginia can limit access to ...

By questioning the FDA's authority to regulate an abortion drug, ... "The FDA approval process is one that is based on extensive, evidence-based, scientific review of efficacy and safety.

At the same time, the FDA announced that it is gutting safety requirements for the two chemical-abortion drugs — mifepristone and misoprostol — in response to a pressure campaign from pro ...

A new study has led to Health and Human Services Secretary Robert F. Kennedy, Jr. to order a “complete review” of the abortion pill, mifepristone, amid queries from Congress.. Sen. Josh Hawley (R-MO) ...

Republican Sen. Josh Hawley’s quest to legitimize a junk science report undermining the safety of a widely used abortion pill was fully realized this week. Food and Drug Administration Commissioner ...

Appeals court embraces abortion-pill limits, sets up Supreme Court review. The Supreme Court has ruled that mifepristone, a key abortion drug, will remain available for now under existing rules ...

Beyond the implications for abortion, the medication abortion case also has consequences for what kind of authority and discretion the FDA has to determine a drug’s safety and appropriate rules ...